Amanote Research

Amanote Research

  • Register
  • Sign In

DPP-4 Inhibitor-Associated Bullous Pemphigoid in a Hemodialysis Patient

Internal Medicine- Japan

doi 10.2169/internalmedicine.3461-19

Full Text

Abstract

Available in

Categories

Internal MedicineMedicine

Date

February 15, 2020

Authors

Jun UsamiYumiko Takezawa

Publisher

Japanese Society of Internal Medicine


Related search

Dipeptidyl Peptidase-4 Inhibitor-Associated Bullous Pemphigoid

2019Indonesian

Bullous Pemphigoid Induced by Vildagliptin: A Case Involving a Maintenance Hemodialysis Patient

Nihon Toseki Igakkai Zasshi
2017English

General Anaesthesia of a Bullous Pemphigoid Patient

Canadian Journal of Anaesthesia
MedicineAnesthesiologyPain Medicine
1996English

HLA-DQB1*03:01 as a Biomarker for Genetic Susceptibility to Bullous Pemphigoid Induced by DPP-4 Inhibitors

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2018English

Bullous Pemphigoid

2020English

Bullous Pemphigoid Associated With Mantle Cell Lymphoma

Archives of Dermatology
2004English

A Case of Rectal Cancer Associated With Bullous Pemphigoid

The journal of the Japanese Practical Surgeon Society
1992English

Bullous Pemphigoid Associated With Cemiplimab Therapy in a Patient With Locally Advanced Cutaneous Squamous Cell Carcinoma

JAAD Case Reports
Dermatology
2020English

A Case of Esophagogastric Junction Cancer Associated With Bullous Pemphigoid

Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association)
2019English

Amanote Research

Note-taking for researchers

Follow Amanote


© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy